Kurma Partners

Sector

#Investor

Subsector

Kurma Partners is a major player in the funding of healthcare and biotechnology in Europe. We invest at various stages of maturity, from company creation to capital expansion. Dedicated funds focus on novel therapeutic solutions, diagnostics, digital healthcare transformation, growth opportunities and sustainable agrifood technologies.

Upcoming events

Latest news

  • V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors

    Wednesday April 24th 2024

  • Labconsort and NEKTARI join forces for a more sustainable and social industry

    Saturday April 20th 2024

  • BIO INX Complements Advisory Board with Distinguished Industry Leaders

    Thursday April 18th 2024